APA (7th ed.) Citation

GG, A., JA, P., PM, P., LB, d. S., LAF, A., BVS, V., . . . H, d. C. S. (2026). Corrigendum to "Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19" [Vaccine 64 (2025) 127756]. Vaccine, 76, 128316. https://doi.org/10.1016/j.vaccine.2026.128316

Chicago Style (17th ed.) Citation

GG, Almeida, et al. "Corrigendum to "Safety and Immunogenicity of SpiN-Tec, a T-cell Based RBD-Nucleocapsid Chimeric Vaccine for COVID-19" [Vaccine 64 (2025) 127756]." Vaccine 76 (2026): 128316. https://doi.org/10.1016/j.vaccine.2026.128316.

MLA (9th ed.) Citation

GG, Almeida, et al. "Corrigendum to "Safety and Immunogenicity of SpiN-Tec, a T-cell Based RBD-Nucleocapsid Chimeric Vaccine for COVID-19" [Vaccine 64 (2025) 127756]." Vaccine, vol. 76, 2026, p. 128316, https://doi.org/10.1016/j.vaccine.2026.128316.